Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt No Debt
OMCL's Cash to Debt is ranked higher than
96% of the 1781 Companies
in the Global Health Information Services industry.

( Industry Median: 20.60 vs. OMCL: No Debt )
Ranked among companies with meaningful Cash to Debt only.
OMCL' s 10-Year Cash to Debt Range
Min: 0.42  Med: 10000.00 Max: No Debt
Current: No Debt
Equity to Asset 0.66
OMCL's Equity to Asset is ranked higher than
58% of the 1579 Companies
in the Global Health Information Services industry.

( Industry Median: 0.61 vs. OMCL: 0.66 )
Ranked among companies with meaningful Equity to Asset only.
OMCL' s 10-Year Equity to Asset Range
Min: -0.57  Med: 0.70 Max: 0.78
Current: 0.66
-0.57
0.78
Interest Coverage No Debt
OMCL's Interest Coverage is ranked higher than
95% of the 1164 Companies
in the Global Health Information Services industry.

( Industry Median: 10000.00 vs. OMCL: No Debt )
Ranked among companies with meaningful Interest Coverage only.
OMCL' s 10-Year Interest Coverage Range
Min: 44.6  Med: 911.20 Max: 9999.99
Current: No Debt
44.6
9999.99
F-Score: 5
Z-Score: 5.16
M-Score: -2.28
WACC vs ROIC
6.91%
11.97%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 10.77
OMCL's Operating margin (%) is ranked higher than
70% of the 1748 Companies
in the Global Health Information Services industry.

( Industry Median: 5.11 vs. OMCL: 10.77 )
Ranked among companies with meaningful Operating margin (%) only.
OMCL' s 10-Year Operating margin (%) Range
Min: -29  Med: 6.61 Max: 11.25
Current: 10.77
-29
11.25
Net-margin (%) 6.82
OMCL's Net-margin (%) is ranked higher than
64% of the 1748 Companies
in the Global Health Information Services industry.

( Industry Median: 3.20 vs. OMCL: 6.82 )
Ranked among companies with meaningful Net-margin (%) only.
OMCL' s 10-Year Net-margin (%) Range
Min: -30.86  Med: 5.05 Max: 20.32
Current: 6.82
-30.86
20.32
ROE (%) 8.10
OMCL's ROE (%) is ranked higher than
55% of the 1703 Companies
in the Global Health Information Services industry.

( Industry Median: 6.27 vs. OMCL: 8.10 )
Ranked among companies with meaningful ROE (%) only.
OMCL' s 10-Year ROE (%) Range
Min: -28.06  Med: 5.48 Max: 28.62
Current: 8.1
-28.06
28.62
ROA (%) 5.61
OMCL's ROA (%) is ranked higher than
62% of the 1788 Companies
in the Global Health Information Services industry.

( Industry Median: 3.29 vs. OMCL: 5.61 )
Ranked among companies with meaningful ROA (%) only.
OMCL' s 10-Year ROA (%) Range
Min: -7.04  Med: 4.01 Max: 17.93
Current: 5.61
-7.04
17.93
ROC (Joel Greenblatt) (%) 57.80
OMCL's ROC (Joel Greenblatt) (%) is ranked higher than
65% of the 1761 Companies
in the Global Health Information Services industry.

( Industry Median: 24.35 vs. OMCL: 57.80 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
OMCL' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -84.84  Med: 45.83 Max: 155.72
Current: 57.8
-84.84
155.72
Revenue Growth (3Y)(%) 18.70
OMCL's Revenue Growth (3Y)(%) is ranked higher than
83% of the 1315 Companies
in the Global Health Information Services industry.

( Industry Median: 5.30 vs. OMCL: 18.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
OMCL' s 10-Year Revenue Growth (3Y)(%) Range
Min: -53.3  Med: 8.75 Max: 18.7
Current: 18.7
-53.3
18.7
EBITDA Growth (3Y)(%) 39.10
OMCL's EBITDA Growth (3Y)(%) is ranked higher than
89% of the 1053 Companies
in the Global Health Information Services industry.

( Industry Median: 6.80 vs. OMCL: 39.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
OMCL' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -14.1  Med: 21.15 Max: 124.1
Current: 39.1
-14.1
124.1
EPS Growth (3Y)(%) 40.40
OMCL's EPS Growth (3Y)(%) is ranked higher than
84% of the 975 Companies
in the Global Health Information Services industry.

( Industry Median: 6.70 vs. OMCL: 40.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
OMCL' s 10-Year EPS Growth (3Y)(%) Range
Min: -69.7  Med: 7.50 Max: 260.9
Current: 40.4
-69.7
260.9
» OMCL's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

OMCL Guru Trades in Q3 2014

Paul Tudor Jones 24,905 sh (+50.47%)
Ken Fisher 492,478 sh (+20.12%)
Jim Simons 90,443 sh (-12.99%)
Joel Greenblatt 35,084 sh (-19.14%)
» More
Q4 2014

OMCL Guru Trades in Q4 2014

Ken Fisher 559,000 sh (+13.51%)
Joel Greenblatt Sold Out
Jim Simons 90,343 sh (-0.11%)
Paul Tudor Jones 9,979 sh (-59.93%)
» More
Q1 2015

OMCL Guru Trades in Q1 2015

Joel Greenblatt 12,112 sh (New)
Paul Tudor Jones 23,222 sh (+132.71%)
Ken Fisher 554,250 sh (-0.85%)
Jim Simons 72,600 sh (-19.64%)
» More
Q2 2015

OMCL Guru Trades in Q2 2015

Jim Simons 90,000 sh (+23.97%)
Joel Greenblatt 12,432 sh (+2.64%)
Paul Tudor Jones Sold Out
Ken Fisher 554,000 sh (-0.05%)
» More
» Details

Insider Trades

Latest Guru Trades with OMCL

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 39.50
OMCL's P/E(ttm) is ranked lower than
69% of the 1109 Companies
in the Global Health Information Services industry.

( Industry Median: 24.00 vs. OMCL: 39.50 )
Ranked among companies with meaningful P/E(ttm) only.
OMCL' s 10-Year P/E(ttm) Range
Min: 8.94  Med: 41.62 Max: 795.88
Current: 39.5
8.94
795.88
Forward P/E 21.41
OMCL's Forward P/E is ranked lower than
57% of the 528 Companies
in the Global Health Information Services industry.

( Industry Median: 19.16 vs. OMCL: 21.41 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 39.60
OMCL's PE(NRI) is ranked lower than
70% of the 1101 Companies
in the Global Health Information Services industry.

( Industry Median: 23.80 vs. OMCL: 39.60 )
Ranked among companies with meaningful PE(NRI) only.
OMCL' s 10-Year PE(NRI) Range
Min: 8.97  Med: 41.72 Max: 676.5
Current: 39.6
8.97
676.5
P/B 3.09
OMCL's P/B is ranked lower than
57% of the 1572 Companies
in the Global Health Information Services industry.

( Industry Median: 2.63 vs. OMCL: 3.09 )
Ranked among companies with meaningful P/B only.
OMCL' s 10-Year P/B Range
Min: 0.96  Med: 2.37 Max: 7.01
Current: 3.09
0.96
7.01
P/S 2.71
OMCL's P/S is ranked lower than
58% of the 1715 Companies
in the Global Health Information Services industry.

( Industry Median: 2.00 vs. OMCL: 2.71 )
Ranked among companies with meaningful P/S only.
OMCL' s 10-Year P/S Range
Min: 0.94  Med: 2.23 Max: 4.69
Current: 2.71
0.94
4.69
PFCF 41.06
OMCL's PFCF is ranked lower than
72% of the 815 Companies
in the Global Health Information Services industry.

( Industry Median: 24.41 vs. OMCL: 41.06 )
Ranked among companies with meaningful PFCF only.
OMCL' s 10-Year PFCF Range
Min: 8.57  Med: 30.70 Max: 142.58
Current: 41.06
8.57
142.58
POCF 25.06
OMCL's POCF is ranked lower than
65% of the 1017 Companies
in the Global Health Information Services industry.

( Industry Median: 17.74 vs. OMCL: 25.06 )
Ranked among companies with meaningful POCF only.
OMCL' s 10-Year POCF Range
Min: 7.42  Med: 18.30 Max: 1010
Current: 25.06
7.42
1010
EV-to-EBIT 22.75
OMCL's EV-to-EBIT is ranked lower than
64% of the 1149 Companies
in the Global Health Information Services industry.

( Industry Median: 16.13 vs. OMCL: 22.75 )
Ranked among companies with meaningful EV-to-EBIT only.
OMCL' s 10-Year EV-to-EBIT Range
Min: -1140.1  Med: 24.55 Max: 424.9
Current: 22.75
-1140.1
424.9
PEG 0.94
OMCL's PEG is ranked higher than
74% of the 487 Companies
in the Global Health Information Services industry.

( Industry Median: 1.75 vs. OMCL: 0.94 )
Ranked among companies with meaningful PEG only.
OMCL' s 10-Year PEG Range
Min: 0.5  Med: 1.52 Max: 42.93
Current: 0.94
0.5
42.93
Shiller P/E 68.97
OMCL's Shiller P/E is ranked lower than
81% of the 699 Companies
in the Global Health Information Services industry.

( Industry Median: 28.94 vs. OMCL: 68.97 )
Ranked among companies with meaningful Shiller P/E only.
OMCL' s 10-Year Shiller P/E Range
Min: 15.61  Med: 37.48 Max: 299.13
Current: 68.97
15.61
299.13
Current Ratio 2.06
OMCL's Current Ratio is ranked higher than
50% of the 1625 Companies
in the Global Health Information Services industry.

( Industry Median: 2.07 vs. OMCL: 2.06 )
Ranked among companies with meaningful Current Ratio only.
OMCL' s 10-Year Current Ratio Range
Min: 0.64  Med: 2.50 Max: 5.21
Current: 2.06
0.64
5.21
Quick Ratio 1.73
OMCL's Quick Ratio is ranked lower than
55% of the 1625 Companies
in the Global Health Information Services industry.

( Industry Median: 1.92 vs. OMCL: 1.73 )
Ranked among companies with meaningful Quick Ratio only.
OMCL' s 10-Year Quick Ratio Range
Min: 0.4  Med: 2.14 Max: 4.95
Current: 1.73
0.4
4.95
Days Inventory 57.63
OMCL's Days Inventory is ranked lower than
77% of the 1028 Companies
in the Global Health Information Services industry.

( Industry Median: 17.89 vs. OMCL: 57.63 )
Ranked among companies with meaningful Days Inventory only.
OMCL' s 10-Year Days Inventory Range
Min: 35.43  Med: 58.69 Max: 128.75
Current: 57.63
35.43
128.75
Days Sales Outstanding 92.46
OMCL's Days Sales Outstanding is ranked lower than
69% of the 1511 Companies
in the Global Health Information Services industry.

( Industry Median: 69.32 vs. OMCL: 92.46 )
Ranked among companies with meaningful Days Sales Outstanding only.
OMCL' s 10-Year Days Sales Outstanding Range
Min: 44.3  Med: 64.69 Max: 88.48
Current: 92.46
44.3
88.48

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 14.75
OMCL's Price/Net Current Asset Value is ranked lower than
74% of the 1036 Companies
in the Global Health Information Services industry.

( Industry Median: 6.56 vs. OMCL: 14.75 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
OMCL' s 10-Year Price/Net Current Asset Value Range
Min: 1.59  Med: 8.35 Max: 33.1
Current: 14.75
1.59
33.1
Price/Tangible Book 9.34
OMCL's Price/Tangible Book is ranked lower than
75% of the 1327 Companies
in the Global Health Information Services industry.

( Industry Median: 4.00 vs. OMCL: 9.34 )
Ranked among companies with meaningful Price/Tangible Book only.
OMCL' s 10-Year Price/Tangible Book Range
Min: 1.2  Med: 5.12 Max: 16.59
Current: 9.34
1.2
16.59
Price/Projected FCF 1.74
OMCL's Price/Projected FCF is ranked lower than
52% of the 823 Companies
in the Global Health Information Services industry.

( Industry Median: 1.66 vs. OMCL: 1.74 )
Ranked among companies with meaningful Price/Projected FCF only.
OMCL' s 10-Year Price/Projected FCF Range
Min: 0.94  Med: 1.44 Max: 50.25
Current: 1.74
0.94
50.25
Price/DCF (Earnings Based) 5.06
OMCL's Price/DCF (Earnings Based) is ranked lower than
89% of the 99 Companies
in the Global Health Information Services industry.

( Industry Median: 1.36 vs. OMCL: 5.06 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.21
OMCL's Price/Median PS Value is ranked lower than
56% of the 1520 Companies
in the Global Health Information Services industry.

( Industry Median: 1.11 vs. OMCL: 1.21 )
Ranked among companies with meaningful Price/Median PS Value only.
OMCL' s 10-Year Price/Median PS Value Range
Min: 0.22  Med: 1.00 Max: 2.2
Current: 1.21
0.22
2.2
Price/Peter Lynch Fair Value 1.58
OMCL's Price/Peter Lynch Fair Value is ranked higher than
52% of the 347 Companies
in the Global Health Information Services industry.

( Industry Median: 1.60 vs. OMCL: 1.58 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
OMCL' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.69  Med: 1.75 Max: 23.38
Current: 1.58
0.69
23.38
Price/Graham Number 4.03
OMCL's Price/Graham Number is ranked lower than
73% of the 853 Companies
in the Global Health Information Services industry.

( Industry Median: 2.03 vs. OMCL: 4.03 )
Ranked among companies with meaningful Price/Graham Number only.
OMCL' s 10-Year Price/Graham Number Range
Min: 1.24  Med: 3.01 Max: 18.72
Current: 4.03
1.24
18.72
Earnings Yield (Greenblatt) (%) 4.40
OMCL's Earnings Yield (Greenblatt) (%) is ranked higher than
58% of the 1711 Companies
in the Global Health Information Services industry.

( Industry Median: 2.80 vs. OMCL: 4.40 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
OMCL' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 0.2  Med: 3.80 Max: 15.9
Current: 4.4
0.2
15.9
Forward Rate of Return (Yacktman) (%) 40.98
OMCL's Forward Rate of Return (Yacktman) (%) is ranked higher than
94% of the 694 Companies
in the Global Health Information Services industry.

( Industry Median: 10.48 vs. OMCL: 40.98 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
OMCL' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -5.2  Med: 17.20 Max: 45
Current: 40.98
-5.2
45

Analyst Estimate

Dec15 Dec16
Revenue(Mil) 495 557
EPS($) 1.18 1.59
EPS without NRI($) 1.18 1.59

Business Description

Industry: Application Software » Health Information Services
Compare:CERN, CTRX, ATHN, MDRX, AH » details
Traded in other countries:OC9.Germany,
Omnicell Inc is a Delaware corporation incorporated in California in 1992 under the name Omnicell Technologies, Inc. and reincorporated in Delaware in 2001 as Omnicell, Inc. The Company is a provider of automation and business information solutions enabling healthcare systems to streamline the medication administration process and manage costly medical supplies for increased operational efficiency and enhanced patient safety. The Company's automation, analytics and medication adherence solutions in hospitals and longer-term care environments are designed to enable healthcare facilities to acquire, manage, dispense and administer medications and medical-surgical supplies and are intended to enhance patient safety, reduce medication errors, reduce operating costs, improve workflow, and increase operational efficiency. Approximately 6,500 hospitals, institutional pharmacies, and retail pharmacies use Company's products. The Company is organized into two operating business segments: Acute Care, which includes products and services sold to hospital customers, and Non-Acute Care, which includes products and services sold to customers outside of the hospital setting. In acute care facilities, its solutions use software‑based medication control and tracking algorithms that interact with hardware security features, resulting in a system that provides both the pharmacist and the nurse real-time safety controls. It also provides medication bar code verification at every step of the medication administration process, from entry to the hospital through the administration of the medication to a patient. Its systems enables customers to reduce or eliminate inefficiencies such as manual tracking and reconciliations, nursing time spent in obtaining medications and in performing inventory control and extraneous process steps. Similar to its medication solutions, Company's medical and surgical supply systems provide hospitals control over consumable supplies critical to providing quality healthcare. Its solutions provide inventory control software that is designed to ensure critical supplies are always stocked in the right locations. It also offers analytics and reporting software for pharmacists and material managers to more easily manage inventory flow, tracking and optimization. The Non-Acute Care segment represents products sold outside the hospital setting and includes medication adherence products sold under the brand name of MTS, and dispensing systems sold under the Omnicell brand. The MTS products consist of proprietary medication packaging systems and related products for use by institutional pharmacies servicing long-term care, and correctional facilities or retail pharmacies serving patients in their local communities. These systems use consumable medication punch cards and specialized machines that allow the pharmacies to automatically or semi-automatically assemble, fill and seal drugs into medication punch cards representing a w
» More Articles for OMCL

Headlines

Articles On GuruFocus.com
Ken Fisher's Top 5 New Portfolio Stocks Jul 27 2014 
comment on OMCL May 26 2013 
Omnicell Inc. (OMCL) V.P., Finance & CFO Robin Gene Seim sells 1,250 Shares Feb 03 2011 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 11,997 Shares Jan 24 2011 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 11,997 Shares Jan 12 2011 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 937 Shares Jan 05 2011 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 3,351 Shares Dec 22 2010 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 1,500 Shares Dec 03 2010 
Omnicell Inc. (OMCL) V.P., Finance & CFO Robin Gene Seim sells 4,265 Shares Nov 30 2010 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 11,372 Shares Oct 22 2010 

More From Other Websites
OMNICELL, INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Aug 20 2015
OMNICELL, INC Financials Aug 20 2015
Omnicell Appoints Peter Kuipers as Chief Financial Officer Aug 20 2015
Omnicell Appoints Peter Kuipers as Chief Financial Officer Aug 20 2015
Stephanie McMahon Among The Insiders Selling Shares Of Their Companies Aug 13 2015
10-Q for Omnicell, Inc. Aug 09 2015
OMNICELL, INC Files SEC form 10-Q, Quarterly Report Aug 07 2015
Omnicell Q2 Earnings Miss, Revenues Up Y/Y; View Retained - Analyst Blog Aug 03 2015
Edited Transcript of OMCL earnings conference call or presentation 30-Jul-15 8:30pm GMT Jul 31 2015
Omnicell misses Street 2Q forecasts Jul 30 2015
Omnicell misses Street 2Q forecasts Jul 30 2015
Omnicell Inc Earnings Call scheduled for 4:30 pm ET today Jul 30 2015
OMNICELL, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 30 2015
Omnicell Announces Second Quarter 2015 Results Jul 30 2015
Omnicell to Release Second Quarter 2015 Earnings Results on July 30th Jul 23 2015
Omnicell to Release Second Quarter 2015 Earnings Results on July 30th Jul 23 2015
LCMC Health Selects Omnicell Medication Automation and Workflow Solutions for Newly Constructed... Jun 24 2015
LCMC Health Selects Omnicell Medication Automation and Workflow Solutions for Newly Constructed... Jun 24 2015
Coverage initiated on Omnicell by Oppenheimer Jun 18 2015
Omnicell's Market Expansion Strong, Margins on a Downswing - Analyst Blog Jun 16 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK